NOUBAR AFEYAN Insider Trading $MRNA Moderna, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOUBAR AFEYAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOUBAR AFEYAN. NOUBAR AFEYAN is Director in AGENUS INC ($AGEN) and Director in BG Medicine, Inc. ($BGMD) and Director in Seres Therapeutics, Inc. ($MCRB) and Director in Moderna, Inc. ($MRNA) and Director in Evelo Biosciences, Inc. ($EVLO) and Director in Rubius Therapeutics, Inc. ($RUBY).
NOUBAR AFEYAN in Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NOUBAR AFEYAN: Director
Holdings: 12,585,162 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NOUBAR AFEYAN in Moderna, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGEN, BGMD, EVLO, MRNA, RUBY, MCRB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.07 | 4,888 | 591,810 | 9,116,657 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.44 | 1,000 | 123,440 | 9,121,545 | 9.1 M to 9.1 M (-0.01 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.08 | 31,943 | 3,931,538 | 9,122,545 | 9.2 M to 9.1 M (-0.35 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.71 | 14,379 | 1,750,038 | 9,154,488 | 9.2 M to 9.2 M (-0.16 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 120.76 | 225,732 | 27,259,283 | 9,168,867 | 9.4 M to 9.2 M (-2.40 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 119.81 | 344,542 | 41,278,061 | 9,394,599 | 9.7 M to 9.4 M (-3.54 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.90 | 611,922 | 72,758,505 | 9,739,141 | 10.4 M to 9.7 M (-5.91 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.04 | 883,277 | 104,265,815 | 10,351,063 | 11.2 M to 10.4 M (-7.86 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 131.30 | 558 | 73,265 | 11,234,340 | 11.2 M to 11.2 M (0.00 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 130.56 | 6,610 | 862,994 | 11,234,898 | 11.2 M to 11.2 M (-0.06 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 129.54 | 83,242 | 10,783,377 | 11,241,508 | 11.3 M to 11.2 M (-0.74 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 128.74 | 123,374 | 15,883,527 | 11,324,750 | 11.4 M to 11.3 M (-1.08 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 127.47 | 46,872 | 5,974,788 | 11,448,124 | 11.5 M to 11.4 M (-0.41 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 126.40 | 82,557 | 10,434,924 | 11,494,996 | 11.6 M to 11.5 M (-0.71 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 125.36 | 116,383 | 14,589,226 | 11,577,553 | 11.7 M to 11.6 M (-1.00 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 124.42 | 251,545 | 31,296,927 | 11,693,936 | 11.9 M to 11.7 M (-2.11 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.50 | 639,681 | 78,998,365 | 11,945,481 | 12.6 M to 11.9 M (-5.08 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 122.54 | 284,300 | 34,836,672 | 12,585,162 | 12.9 M to 12.6 M (-2.21 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 150.41 | 35,000 | 5,264,350 | 12,869,462 | 12.9 M to 12.9 M (-0.27 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.91 | 99,005 | 14,742,765 | 12,904,462 | 13 M to 12.9 M (-0.76 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.01 | 267,038 | 39,523,921 | 13,003,467 | 13.3 M to 13 M (-2.01 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 147.17 | 288,656 | 42,481,157 | 13,270,505 | 13.6 M to 13.3 M (-2.13 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 146.05 | 351,112 | 51,281,277 | 13,559,161 | 13.9 M to 13.6 M (-2.52 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 145.04 | 354,358 | 51,396,616 | 13,910,273 | 14.3 M to 13.9 M (-2.48 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 144.17 | 358,528 | 51,688,838 | 14,264,631 | 14.6 M to 14.3 M (-2.45 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 151.29 | 23,423 | 3,543,551 | 14,623,159 | 14.6 M to 14.6 M (-0.16 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 150.51 | 190,710 | 28,704,468 | 14,646,582 | 14.8 M to 14.6 M (-1.29 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 149.63 | 179,268 | 26,823,154 | 14,837,292 | 15 M to 14.8 M (-1.19 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 148.52 | 268,688 | 39,905,810 | 15,016,560 | 15.3 M to 15 M (-1.76 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 147.57 | 292,483 | 43,162,565 | 15,285,248 | 15.6 M to 15.3 M (-1.88 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 146.64 | 307,795 | 45,134,105 | 15,577,731 | 15.9 M to 15.6 M (-1.94 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 145.48 | 357,316 | 51,982,439 | 15,885,526 | 16.2 M to 15.9 M (-2.20 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 144.55 | 405,551 | 58,623,573 | 16,242,842 | 16.6 M to 16.2 M (-2.44 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 143.57 | 397,126 | 57,017,127 | 16,648,393 | 17 M to 16.6 M (-2.33 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 142.76 | 117,011 | 16,704,549 | 17,045,519 | 17.2 M to 17 M (-0.68 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 141.46 | 70,631 | 9,991,271 | 17,162,530 | 17.2 M to 17.2 M (-0.41 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 140.24 | 102,852 | 14,423,553 | 17,233,161 | 17.3 M to 17.2 M (-0.59 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 139.65 | 56,435 | 7,880,849 | 17,336,013 | 17.4 M to 17.3 M (-0.32 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 138.56 | 46,222 | 6,404,451 | 17,392,448 | 17.4 M to 17.4 M (-0.27 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 137.29 | 122,142 | 16,768,948 | 17,438,670 | 17.6 M to 17.4 M (-0.70 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 136.48 | 9,985 | 1,362,773 | 17,560,812 | 17.6 M to 17.6 M (-0.06 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 170.03 | 30,968 | 5,265,421 | 17,570,797 | 17.6 M to 17.6 M (-0.18 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 169.14 | 54,274 | 9,179,910 | 17,601,735 | 17.7 M to 17.6 M (-0.31 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 168.11 | 58,377 | 9,813,857 | 17,656,009 | 17.7 M to 17.7 M (-0.33 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 167.10 | 122,715 | 20,505,750 | 17,714,386 | 17.8 M to 17.7 M (-0.69 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 166.30 | 351,578 | 58,466,296 | 17,837,101 | 18.2 M to 17.8 M (-1.93 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 165.47 | 165,578 | 27,397,976 | 18,188,311 | 18.4 M to 18.2 M (-0.90 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 164.14 | 189,200 | 31,054,266 | 18,353,889 | 18.5 M to 18.4 M (-1.02 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 163.25 | 366,471 | 59,827,380 | 18,543,089 | 18.9 M to 18.5 M (-1.94 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 162.36 | 250,501 | 40,672,044 | 18,909,560 | 19.2 M to 18.9 M (-1.31 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 160.96 | 30,808 | 4,958,809 | 19,160,061 | 19.2 M to 19.2 M (-0.16 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 160.37 | 54,409 | 8,725,620 | 19,190,869 | 19.2 M to 19.2 M (-0.28 %) |
| Feb 24 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 159.18 | 161,887 | 25,769,076 | 19,245,278 | 19.4 M to 19.2 M (-0.83 %) |
| Apr 30 2020 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
| Jun 28 2019 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 14.34 | 54,660 | 783,824 | 54,660 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 21,496 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 85,989 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,428,432 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 5,713,739 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 6,195,632 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 24,782,551 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,823,036 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 7,292,145 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 21,496 | 0 | 9,468,596 | 9.4 M to 9.5 M (+0.23 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 85,989 | 0 | 37,874,424 | 37.8 M to 37.9 M (+0.23 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 1,428,432 | 0 | 9,447,100 | 8 M to 9.4 M (+17.81 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 5,713,739 | 0 | 37,788,435 | 32.1 M to 37.8 M (+17.81 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 6,195,632 | 0 | 8,018,668 | 1.8 M to 8 M (+339.85 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 24,782,551 | 0 | 32,074,696 | 7.3 M to 32.1 M (+339.85 %) |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 1,823,036 | 0 | 1,823,036 | 0 to 1.8 M |
| Dec 13 2018 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 7,292,145 | 0 | 7,292,145 | 0 to 7.3 M |
Page: 1